Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia
Open Access
- 21 November 2011
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 31 (30) , 3536-3546
Abstract
Despite recent progress in the treatment of acute myeloid leukemia (AML), the prognosis of this rather heterogeneous disease remains poor and novel chemotherapeutics that specifically target leukemic cells must be developed. To address this need at the preclinical level, we implemented a high content imaging-based screen for the identification of small agents that induce AML cell death in vitro. Among a panel of 1040 Food and Drug Administration-approved agents, we identified pyrithione zinc (PZ) and ouabain (OUA) as potential antileukemic compounds. Both PZ and OUA efficiently induced cell death associated with apoptotic chromatin condensation and inhibition of nuclear factor-κB survival signaling, leading to reduced expression of antiapoptotic proteins, in several AML cell lines. PZ- and OUA-induced cell death was associated with the permeabilization of the outer mitochondrial membrane and led to the release of cytochrome c followed by caspase activation. Both PZ and OUA exerted significant anticancer effects in vivo, on human AML cells xenografts as well as ex vivo, on CD34+ (but not CD34−) malignant myeloblasts from AML patients. Altogether, our results suggest that PZ and OUA may exhibit antileukemic effects by inducing the apoptotic demise of AML cells.Keywords
This publication has 32 references indexed in Scilit:
- Zinc pyrithione impairs zinc homeostasis and upregulates stress response gene expression in reconstructed human epidermisBioMetals, 2011
- Ex Vivo Activity of Cardiac Glycosides in Acute LeukaemiaPLOS ONE, 2011
- The topical antimicrobial zinc pyrithione is a heat shock response inducer that causes DNA damage and PARP-dependent energy crisis in human skin cellsCell Stress and Chaperones, 2010
- Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein SynthesisPLOS ONE, 2009
- Proteomic and Genetic Approaches Identify Syk as an AML TargetCancer Cell, 2009
- Cardiac Glycosides Inhibit p53 Synthesis by a Mechanism Relieved by Src or MAPK InhibitionCancer Research, 2009
- Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotesCell Death & Differentiation, 2009
- Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of SagopiloneCancer Research, 2008
- Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent PathwayPLOS ONE, 2007
- Methods for the assessment of mitochondrial membrane permeabilization in apoptosisApoptosis, 2007